Posted on

A Gene Sequencing Pioneer Battles Over What It Can Buy

Illumina, the leading maker of gene-sequencing machines, is tiny compared with the tech giants of Silicon Valley. But like Google and Facebook, Illumina now finds itself in the cross hairs […]




Posted on

Regulators Can’t Make Their Minds Up About Crypto

The trans-Atlantic antitrust danceThe review of an $8 billion deal between the life sciences companies Illumina and Grail may point to a new playbook for antitrust enforcement. Regulators are looking […]